Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 HKD | +5.77% | -.--% | -63.93% |
05-10 | Central China Management Contracted Sales Decline in January-April Period | MT |
04-09 | Central China Management Contracted Sales Decline in the First Quarter | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Its low valuation, with P/E ratio at 1.38 and 1.22 for the ongoing fiscal year and 2024 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company is one of the best yield companies with high dividend expectations.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Construction & Engineering
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-63.93% | 54.43M | - | ||
+1.85% | 71.31B | C+ | ||
-6.17% | 54.23B | C+ | ||
+23.00% | 38.86B | B+ | ||
+15.38% | 31.94B | B | ||
+6.12% | 27.7B | A- | ||
+19.89% | 21.72B | B- | ||
+17.68% | 19.92B | A | ||
+73.40% | 17.56B | B | ||
+36.78% | 18.01B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 9982 Stock
- Ratings Central China Management Company Limited